Today, about 7% of all health care expenditures in Russia are spent on diabetes mellitus. The actual number of patients with diabetes mellitus in Russia is at least 9 million people (about 6% of the population).

The statistics are not encouraging, but the medical community tries to draw attention to this serious disease on an annual basis by virtue of holidays such as World Diabetes Day.

Today, each of us has a relative or acquaintance suffering from this disease. The main reason for multiplication of the affected ones is a change in the lifestyle of the population that has been begun in the middle of the last century and continuing to this day: physical inactivity, irrational diet, smoking and alcohol abuse.

It is important that diabetes mellitus (especially type 2) can be prevented and complications can be practically eliminated with a full understanding of the disease causes and relevant prophylaxis measures.

The Pharmasyntez Group of Companies has been actively supporting the type 2 diabetes mellitus management and working at the saturation of the domestic market with affordable up-to-date Russian-made drugs that are non-inferior in quality than foreign analogues.

Pharmasyntez-Tyumen being a part of the Pharmasyntez Group of Companies is a holder of the largest portfolio of antihyperglycemic agents for the treatment of type 2 diabetes mellitus (8 trade names).

Type 2 diabetes mellitus can be prevented. The most significant is to develop a habit of healthy lifestyle.

Picture: Artem Podrez: Pexels